Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05842902 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Resilience Mobile App for Teens and Young Adults With Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jun 1, 2027 → Aug 1, 2027
See other at-risk trials from Seattle Children's Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 1, 2027 to Aug 1, 2027v7
  2. Primary completion date: Jan 31, 2027 to Jun 1, 2027
    • Study completion date: Aug 31, 2027 to Jun 1, 2027
    v6
  3. Enrollment target: 120 to 80
    • Eligibility criteria revised
    • Secondary endpoints: 11 to 5
    v5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Dec 31, 2026 to Jan 31, 2027
    • Start date changed from estimate of Aug 1, 2023 to Sep 12, 2023
    • Secondary endpoints: 9 to 11
  5. Start date: May 1, 2023 to Aug 1, 2023
    • Primary completion date: Aug 31, 2026 to Dec 31, 2026
    v3
  6. Secondary endpoints: details revised at 4 of 9 entriesv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
Trial Details
NCT Number NCT05842902
Lead Sponsor Seattle Children's Hospital
Collaborators: University of Washington
Conditions
(from sponsor)		 Cancer
Related terms Neoplasms
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov